Australian Clinical Labs Limited (ASX:ACL) Increases Dividend to $0.09 Per Share

Australian Clinical Labs Limited (ASX:ACL) declared a final dividend on Monday, September 2nd, MarketIndexAU reports. Stockholders of record on Thursday, September 26th will be given a dividend of 0.09 per share on Thursday, September 26th. This represents a dividend yield of 2.87%. The ex-dividend date is Tuesday, September 3rd. This is an increase from Australian Clinical Labs’s previous final dividend of $0.07.

Australian Clinical Labs Price Performance

The company has a debt-to-equity ratio of 173.77, a quick ratio of 0.53 and a current ratio of 0.64.

About Australian Clinical Labs

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services.